Melatonin prevents lipopolysaccharide-induced hyporeactivity in rat

被引:33
作者
Bianca, RDD
Marzocco, S
Rosanna, DP
Autore, G
Pinto, A
Cuzzocrea, S
Sorrentino, R
机构
[1] Dipartimento Clin Sperimentale Med & Farmacol, I-98100 Messina, Italy
[2] Univ Naples Federico II, Dipartimento Farmacol Sperimentale, Naples, Italy
[3] Univ Salerno, Dipartimento Sci Farmaceut, Fisciano, SA, Italy
关键词
aorta; hyporeactivity; inducible nitric oxide synthase; lipopolysaccharide; melatonin; poly (ADP-ribose) synthetase; rat;
D O I
10.1046/j.1600-079X.2003.00111.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Melatonin (MT) is the principal secretory product of the pineal gland and its role as an immumo-modulator is well established. Recent evidence shows that MT exerts protective effects in septic shock, hemorrhagic shock and inflammation. Lipopolysaccharide (LPS), from Escherichia coli, administered to animals directly stimulates a number of cells and systems to produce various inflammatory mediators. LPS-induced septic shock is characterized by hypotension and vascular hyporeactivity to contracting agents. In particular, the reactive oxygen species such as superoxide and nitric oxide (NO) contribute to the pathophysiology of septic shock. In this study, we demonstrate that MT pretreatment prevents the hyporeactivity to phenylephrine in vivo and in aorta rings collected from rats treated with the endotoxin. The beneficial effect of MT seems related to its antioxidant properties and with inhibition of inducible nitric oxide synthase (iNOS) protein expression, reduction of NO production and nitrotyrosine formation, in aorta, preventing vascular, and endothelial injury. Additionally, we first demonstrate, that MT inhibited nuclear enzyme poly (ADP-ribose) synthetase activation in vascular tissue. The current study underlined the protective effect of MT on the vascular dysfunction associated with septic shock, data that could support the clinical use of MT in human endotoxemia.
引用
收藏
页码:146 / 154
页数:9
相关论文
共 53 条
[1]   The chemistry of melatonin's interaction with reactive species [J].
Allegra, M ;
Reiter, RJ ;
Tan, DX ;
Gentile, C ;
Tesoriere, L ;
Livrea, MA .
JOURNAL OF PINEAL RESEARCH, 2003, 34 (01) :1-10
[2]  
Annane D, 2001, J ENDOTOXIN RES, V7, P305
[3]   Mechanisms of bacterial lipopolysaccharide-induced endothelial apoptosis [J].
Bannerman, DD ;
Goldblum, SE .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 284 (06) :L899-L914
[4]   APPARENT HYDROXYL RADICAL PRODUCTION BY PEROXYNITRITE - IMPLICATIONS FOR ENDOTHELIAL INJURY FROM NITRIC-OXIDE AND SUPEROXIDE [J].
BECKMAN, JS ;
BECKMAN, TW ;
CHEN, J ;
MARSHALL, PA ;
FREEMAN, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (04) :1620-1624
[5]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[6]   Smooth muscle dysfunction in resistance arteries of the staggerer mouse, a mutant of the nuclear receptor RORα [J].
Besnard, S ;
Bakouche, J ;
Lemaigre-Dubreuil, Y ;
Mariani, J ;
Tedgui, A ;
Henrion, D .
CIRCULATION RESEARCH, 2002, 90 (07) :820-825
[7]   The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion [J].
Cheung, RTF .
JOURNAL OF PINEAL RESEARCH, 2003, 34 (03) :153-160
[8]   Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats [J].
Crespo, E ;
Macías, M ;
Pozo, D ;
Escames, G ;
Martin, M ;
Vives, F ;
Guerrero, JM ;
Acuña-Castroviejo, D .
FASEB JOURNAL, 1999, 13 (12) :1537-1546
[9]   Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury [J].
Cuzzocrea, S ;
Mazzon, E ;
Costantino, G ;
Serraino, I ;
De Sarro, A ;
Caputi, AP .
CARDIOVASCULAR RESEARCH, 2000, 47 (03) :537-548
[10]   Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia [J].
deWerra, I ;
Jaccard, C ;
Corradin, SB ;
Chiolero, R ;
Yersin, B ;
Gallati, H ;
Assicot, M ;
Bohuon, C ;
Baumgartner, JD ;
Glauser, MP ;
Heumann, D .
CRITICAL CARE MEDICINE, 1997, 25 (04) :607-613